Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Hypertension. 2022 Jun 28;79(9):2042–2050. doi: 10.1161/HYPERTENSIONAHA.121.18765

Table 1.

Description of the study population (means, standard deviations or frequencies).

Characteristics Low (L) Mid (M) High (H)
N=155 N=88 N=139
Age (years)* 15.6 ± 1.6 15.9 ± 1.8 15.3 ± 1.9
Race (% non-White 25.0 37.9 37.1
Sex (% Male) 52.3 71.6 61.2
Height (cm)* 168.7 ± 9.1 171.8 ± 10.9 168.5 ± 9.9
Weight (kg) 76.7 ± 23.3 85.6 ± 29.0 84.8 ± 25.0
BMI (kg/m2)§ 26.7 ± 7.0 28.7 ± 8.6 29.7 ± 7.9
BMI percentile (%)§ 78.0 ± 41.5 80.6 ± 20.9 86.4 ± 20.9
Obese (%)§ 36.1 46.6 54.7
Waist (cm)§ 86.1 ± 18.8 89.1 ± 19.5 93.5 ± 19.7
Waist/height ratio|| 0.5 ± 0.1 0.5 ± 0.1 0.6 ± 0.1
Total cholesterol (mg/dl) 152.0 ± 30.1 153.8 ±34.8 154.3 ± 33.2
LDL (mg/dl) 86.6 ± 26.9 90.7 ± 28.8 92.5 ± 28.4
HDL (mg/dl)# 47.4 ± 12.2 44.1 ± 11.5 43.3 ± 11.7
Triglycerides (mg/dl) 94.5 ± 62.2 99.4 ± 58.6 96.3 ± 48.8
Glucose (mg/dl)§ 87.9 ± 8.0 89.5 ± 10.4 90.8 ± 8.2
Insulin (microIU/dl)§ 17.9 ± 14.4 20.0 ± 14.4 23.8 ± 19.0
HOMA_IR§ 3.98 ± 3.46 4.47 ± 3.31 5.48 ± 4.78
CRP (mg/dl)§ 1.30 ± 1.69 1.39 ± 1.74 1.95 ± 2.16
Creatinine (mg/dl)** 0.72 ± 0.13 0.79 ± 0.18 0.72 ± 0.17
Uric acid (mg/dl)§ 5.41 ± 1.63 5.81 ± 1.40 6.04 ± 1.52
Urine sodium/potassium ratio 4.09 ± 3.01 4.19 ± 3.16 3.99 ± 2.64

Bonferroni adjusted P≤0.04 for

*

H<M

M<L

L<M&H

§

L< H

||

L&M<H

#

H<L

**

L&H<M

BMI, body mass index; CRP, C-reactive protein; DBP, diastolic blood pressure; HDL, high density lipoprotein; HR, heart rate; K1, Korotkoff sound 1; K5, Korotkoff sound 5; LDL, low density lipoprotein; MAP, mean arterial pressure; SBP, systolic blood pressure.